Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naveen Kella

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Urology|May 2, 2012
Unusual presentation of bilateral ureteroceles with ureterolithiasis in a patient after robotic prostatectomyToby Lees, Naveen Kella
Reviews in Urology|September 21, 2006
Rising prostate-specific antigen level after prostatectomyNaveen Kella, Kevin M Slawin
Current Medical Research and Opinion|May 8, 2014
Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT studySteven N Michalopoulos, Naveen Kella, Ryan Payne, et al.
The Journal of Urology|January 20, 2016
A Parallel Randomized Clinical Trial Examining the Return of Urinary Continence after Robot-Assisted Radical Prostatectomy with or without a Small Intestinal Submucosa Bladder Neck SlingClinton D Bahler, Chandru P Sundaram, Naveen Kella, et al.
BJU International|May 3, 2014
Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgeryKetan K Badani, Darby J Thompson, Gordon Brown, et al.
Urology|October 13, 2018
Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4)David Albala, Michael S Manak, Jonathan S Varsanik, et al.
The Journal of Urology|September 26, 2015
Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate CancerNeal D Shore, Naveen Kella, Brian Moran, et al.
The Journal of Urology|June 10, 2026
Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and ToxicityArvin George, Eric Giesler, Brian Mazzarella, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Urology|May 2, 2012
Unusual presentation of bilateral ureteroceles with ureterolithiasis in a patient after robotic prostatectomyToby Lees, Naveen Kella
Reviews in Urology|September 21, 2006
Rising prostate-specific antigen level after prostatectomyNaveen Kella, Kevin M Slawin
Current Medical Research and Opinion|May 8, 2014
Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT studySteven N Michalopoulos, Naveen Kella, Ryan Payne, et al.
The Journal of Urology|January 20, 2016
A Parallel Randomized Clinical Trial Examining the Return of Urinary Continence after Robot-Assisted Radical Prostatectomy with or without a Small Intestinal Submucosa Bladder Neck SlingClinton D Bahler, Chandru P Sundaram, Naveen Kella, et al.
BJU International|May 3, 2014
Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgeryKetan K Badani, Darby J Thompson, Gordon Brown, et al.
Urology|October 13, 2018
Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4)David Albala, Michael S Manak, Jonathan S Varsanik, et al.
The Journal of Urology|September 26, 2015
Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate CancerNeal D Shore, Naveen Kella, Brian Moran, et al.
The Journal of Urology|June 10, 2026
Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and ToxicityArvin George, Eric Giesler, Brian Mazzarella, et al.
Pageof 1